LD-2 disclosure · 1st Quarter - Report
AMYLIN PHARMACEUTICALS
Client
- Location
- District of Columbia · United States of America
Registrant
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
5 issuesMedical/Disease Research/Clinical Labs
Comparative Effectiveness Diabetes research issues LHHS appropriations
LobbyistsMERCEDES BARRS · PETER NORMAN · mr WILLIAM A FRANCO
TargetedSENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP) · Health & Human Services, Dept of (HHS) · Food & Drug Administration (FDA)
Copyright/Patent/Trademark
S. 1145, Patent Reform Act of 2007, entire bill HR 1908, Patent Reform Act of 2007, entire bill
LobbyistsMERCEDES BARRS · PETER NORMAN · mr WILLIAM A FRANCO
TargetedSENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP) · Health & Human Services, Dept of (HHS) · Food & Drug Administration (FDA)
Budget/Appropriations
FY09 Adminstration Budget House Concurrent Resolution 312 FY09 Revised Congressional Budget Senate Concurrent Resolution 70 FY09 Congresisonal Budget Comparative Effectiveness FDA/drug importation
LobbyistsMERCEDES BARRS · PETER NORMAN · mr WILLIAM A FRANCO
SENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP) · Health & Human Services, Dept of (HHS) · Food & Drug Administration (FDA)